Lessee, Operating Lease, Liability, to be Paid in USD of Inmune Bio, Inc. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Inmune Bio, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q2 2019 to Q3 2025.
  • Inmune Bio, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $1.2M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.2M 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $505K -$30K -5.61% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $393K -$188K -32.4% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $442K -$186K -29.6% 31 Dec 2024 10-K 27 Mar 2025
Q2 2024 $535K 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $581K 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $628K 31 Dec 2023 10-K 28 Mar 2024
Q4 2021 $488K 31 Dec 2021 10-Q 31 Oct 2024
Q3 2019 $242K 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $242K 30 Jun 2019 10-Q 09 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.